logo
logo

Ucello Therapeutics Completes Us$25 Million Series A Financing

Ucello Therapeutics Completes Us$25 Million Series A Financing

02/10/22, 1:16 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan diego
Money raised
$25 million
Round Type
series a
Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of a US$25 million Series A financing.

Company Info

Company
Ucello Therapeutics
Location
san diego, california, united states
Additional Info
Ucello Therapeutics, established in December 2020 in Chengdu Tianfu International Bio-town, is a privately held biotechnology company focused on the development of allogeneic cell therapies. Powered by its proprietary universal CAR-T cell technology platform CBT-X20, Ucello has developed several "off-the-shelf" cell therapy pipelines for the treatment of solid tumors and hematologic malignancies, and potentially change the landscape of CAR-T cell therapy.